landiolol has been researched along with Left Ventricular Outflow Obstruction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, Y; Inoue, K; Kunimoto, M; Minamino, T | 1 |
| Fukui, K; Hashiba, E; Hashimoto, H; Hirota, K; Itoh, K; Kushikata, T | 1 |
2 other study(ies) available for landiolol and Left Ventricular Outflow Obstruction
| Article | Year |
|---|---|
Haemodynamic effects of acute intravenous landiolol in Takotsubo cardiomyopathy with dynamic left ventricular outflow tract obstruction.
Topics: Cardiomyopathy, Hypertrophic; Hemodynamics; Humans; Mitral Valve; Mitral Valve Insufficiency; Takotsubo Cardiomyopathy; Ventricular Outflow Obstruction; Ventricular Outflow Obstruction, Left | 2023 |
[Case in which landiolol hydrochloride improved left ventricular outflow tract obstruction with systolic anterior motion of the mitral valve following mitral valve plasty].
Topics: Adrenergic beta-Antagonists; Aged; Heart Valve Prosthesis Implantation; Humans; Male; Mitral Valve; Mitral Valve Insufficiency; Morpholines; Postoperative Complications; Shock; Systole; Treatment Outcome; Urea; Ventricular Outflow Obstruction | 2006 |